Fintepla (Fenfluramine)

Fintepla (fenfluramine) is an amphetamine derivative used for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients aged 2 years and older.

Recommended Dosage: The recommended dosage of Fenfluramine oral solution is administered orally and may be taken with or without food.
Dravet Syndrome: The recommended initial starting and maintenance dosage is 0.1 mg/kg twice daily, which can be increased weekly depending on efficacy and tolerability. The maximum daily maintenance dosage is 0.35 mg/kg twice daily (maximum daily dosage of 26 mg).
Lennox-Gastaut Syndrome: The recommended initial starting dosage is 0.1 mg/kg twice daily, which should be increased weekly depending on tolerability. The recommended maintenance dosage is 0.35 mg/kg twice daily (maximum daily dosage of 26 mg).
Dravet Syndrome and Lennox-Gastaut Syndrome: Dosage can be adjusted in patients taking concomitant stiripentol plus clobazam: the maximum daily maintenance dosage is 0.2 mg/kg twice daily (maximum daily dosage of 17 mg).

• Treatment with Fenfluramine 2.2 mg/mL may increase the chance of developing pulmonary arterial hypertension and valvular heart disease. Patients with a prior history of cardiac issues should have regular check-ups. Notify your healthcare provider (HCP) in case you experience any breathing difficulties, swelling, or chest pain.
• Fenfluramine can cause decreased appetite and weight loss. This may cause poor nutritional intake, mainly in children or those who have difficulty in maintaining weight. Monitor weight regularly and consult your healthcare provider (HCP) in case excessive weight loss occurs.
• Treatment with this medicine may cause somnolence (drowsiness), sedation, or lethargy. These effects can impair your potential to do daily activities. Do not operate machinery or drive until you understand how this therapeutic drug affects you, and notify your doctor in case symptoms persist or worsen.
• People with a prior mental health history are at risk of developing suicidal ideations due to the use of fenfluramine. Such patients need close supervision by family members and caregivers just like other patients undergoing treatment, they need supervision during the initial treatment process for mood, thoughts, and behavioral changes.
• Withdrawal from an antiepileptic drug during the use of fenfluramine can increase the chances of seizures occurring. Gradual discontinuation under supervision is the only safe option in this case of prescribing fenfluramine and antiepileptics together. Follow your doctor’s orders without question.
• Fenfluramine 2.2 mg/mL raises the chances of developing serotonin syndrome, which can be a serious threat to someone’s life. Some of the symptoms include agitation, jumpiness, confusion, high temperature, a racing heart, and muscle stiffness. If you notice any of these symptoms, it is crucial to get medical assistance. Avoid delays as addressing serotonin syndrome too late may result in life-threatening complications.
• This medicinal product can contribute to a rise in one’s blood pressure. Monitor the blood pressure of individuals with hypertension or those taking blood pressure medications. Significant shifts in blood pressure readings must be communicated to the respective healthcare provider (HCP).
• Treatment with this medicine may increase intraocular pressure and worsen glaucoma. If you have a known history of eye disorders, especially glaucoma, discuss all the risks with your doctor. Regular eye exams are required to monitor for any signs of increased eye pressure or vision changes.
• Avoid the use of Fenfluramine during pregnancy and breastfeeding unless prescribed by a doctor. It may cause harm the fetus or pass into breast milk. If you are pregnant, want to become pregnant, or are breastfeeding, consult your healthcare provider (HCP) before use.

What documents are required to import FINTEPLA to India?

FINTEPLA (fenfluramine) oral solution can be imported by patients or government hospitals in the patients' name only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is FINTEPLA available in India?

FINTEPLA (fenfluramine oral solution) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Fintepla in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait,
• Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

FINTEPLA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of FINTEPLA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Fintepla 2.2 mg/mL price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source FINTEPLA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Fintepla®?

Fenfluramine is a Generic Name for the trade name drug Fintepla®.

What is the Manufacturer's Name of Fintepla®?

Fintepla® is manufactured by UCB, Inc.

Is Fintepla® approved by the FDA?

Yes, Fintepla® is approved by the FDA. Date of first approval: June 25, 2020.

What is the dosage and form of Fintepla® supplied?

Fintepla is supplied in oral solution: 2.2 mg/mL fenfluramine for oral administration.

What are the most common side effects of Fintepla®?

The most common side effects of Fintepla® are decreased appetite, somnolence, vomiting, lethargy, diarrhea, sedation, fatigue, constipation, malaise, asthenia, ataxia, balance disorder, blood pressure increased; drooling, abnormal echocardiogram, salivary hypersecretion, pyrexia; upper respiratory tract infection, decreased weight, fall, gait disturbance, and status epilepticus.

How much does the Fintepla® 2.2 mg/mL Oral Solution cost in India?

Prices of Fintepla may fluctuate over time due to market dynamics and regulatory changes. To get the most accurate and latest details on Fintepla oral Solution cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Fintepla® be available in SAARC countries?

Apart from Gulf countries, Fintepla® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Fintepla® oral solutions in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Fintepla® 2.2 mg/mL Oral Solution online in India?

Yes, one can buy Fintepla 2.2 mg/mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Fintepla® oral solutions through legal channels.

What are the storage conditions of Fintepla® 2.2 mg/mL Oral Solution?

Store at room temperature between 20 to 25°C (68 to 77°F); excursions are permitted between 15 to 30°C (59 to 86°F). It is not advisable to refrigerate or freeze it. Store the bottle as well as syringe together.